about
Identification of a novel human adenylate kinase. cDNA cloning, expression analysis, chromosome localization and characterization of the recombinant proteinPhosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzymeMammalian 5'(3')-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cellsHuman UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondriaThe characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymesCloning and expression of human deoxyguanosine kinase cDNACloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitroEvidence of an intact N-terminal translocation sequence of human mitochondrial adenylate kinase 4The human adenylate kinase 9 is a nucleoside mono- and diphosphate kinaseThe lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophilsHuman deoxycytidine kinase is located in the cell nucleusCytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophilsThe two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptideThe human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinaseSynthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitorsNucleoside diphosphate kinase. Investigation of the intersubunit contacts by site-directed mutagenesis and crystallographyReview of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndromePhosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinasesIdentification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophilsThe synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different ReceptorsLocalization of the human deoxyguanosine kinase gene (DGUOK) to chromosome 2p13Depletion of mitochondrial DNA by down-regulation of deoxyguanosine kinase expression in non-proliferating HeLa cellsNovel ribofuranosylnucleoside lead compounds for potent and selective inhibitors of mitochondrial thymidine kinase-2Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutantsResistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives)Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analoMechanism of anti-HIV action of masked alaninyl d4T-MP derivativesCharacteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1Cloning of mouse mitochondrial thymidine kinase 2 cDNAProgressive loss of mitochondrial DNA in thymidine kinase 2-deficient miceThe Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry InhibitionSubstrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinasesThe presence of stomatin in detergent-insoluble domains of neutrophil granule membranes.Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug designNovel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity.Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1.
P50
Q22009450-6804A868-52F4-4CE4-9A3C-D08CA0F1264DQ22010485-E3342833-1E63-47AA-908E-EA6136472EB5Q22253218-2D2E1A55-347C-4D55-8394-C05370FBF66EQ24300329-628FBC22-C71F-4B6B-96AE-F83A62C73BD0Q24307438-A8D41C72-5ABC-422D-8E92-1EDD413AD6E3Q24309567-DBA9CAF0-5260-42FF-A29F-22EA57BE48F0Q24310289-D98D7738-1FE0-4DCA-8C54-06CD06D35021Q24315918-C6110FCE-10A1-460C-A72E-874A5E7597C8Q24317563-FB8984C2-32E6-4DEA-87D5-89B620FD9005Q24317654-D06E30C0-295E-4F04-BA75-BA708F511A5AQ24528214-1E595348-F51C-4331-8B85-90A0E13A62F0Q24647240-3D6AD0FC-6D02-4187-8A08-43D34E690B01Q24800189-94E21C86-1BDF-4E4C-AA7E-B1A2BFADA1BBQ24808945-BD0BCA12-C9FD-4DC5-AAD5-90144197252EQ27622383-FE497A5F-B129-4583-911C-939418B2100EQ27629414-4EBA811F-1665-4296-9717-AC4967661B35Q27733171-33356E28-BD42-4FDD-8A89-41C8D96EFB79Q28066401-36C77F22-2F9B-47D0-8C49-C16554FCA7BBQ28139775-4EE77D51-3B71-4A5C-B244-7975E73B7A90Q28146253-45752203-E070-4246-B815-E9D0DB0529DCQ28210329-ABE1858B-B97D-4FA9-9DFC-543DCC4AAA2BQ28212653-B1900D85-2893-404F-9638-C1D0CFCD28C2Q28289800-594A670B-6E6B-4C3A-B33A-ADF5F78934B0Q28300018-EF47AC93-F4F6-41BC-9B52-44690E447442Q28301439-38F1BA5D-6ADC-4BB5-91E7-6FAA51EC441CQ28344795-4C120303-CDA7-4E92-879C-2E6DA8CA511EQ28367570-97E0526E-5C62-4869-87DD-6FEE02F29F43Q28367603-14BE3E88-51CC-4153-B37E-148063221F64Q28367704-D3680B54-B483-4F2F-B7CB-1FF4A7F66824Q28368045-B061DB7A-0121-4023-A9D3-56716B9C7065Q28378931-4CA6DC0F-14A9-46FB-8C87-8AA953BFCD29Q28379192-FF4E398C-5B4B-46E8-9D47-C69B32F08B34Q28504701-7BC98647-DCB0-46C8-8F45-CB136EF9034FQ28513054-43766BF8-A7EB-4B4B-B582-1AE850EA0500Q28552932-CC7FD58F-8E58-49C2-937D-1CE935F66CF5Q28620349-47ECB6B9-7E87-4F35-92E3-95CC2716FBEEQ30870276-68F052B5-749B-443D-8B97-A052C30E8343Q33261402-1E1D1EFD-5D5C-4614-9989-8DE8B8FBCF0FQ33275658-00BE7994-EE0C-4185-922E-AF51FB152CB5Q33738946-2282F4F5-5DC1-4CAF-8093-26BDBE43D5F4
P50
description
Zweeds onderzoekster
@nl
hulumtuese
@sq
researcher
@en
svensk forsker
@nb
հետազոտող
@hy
name
Anna Karlsson
@ast
Anna Karlsson
@da
Anna Karlsson
@de
Anna Karlsson
@en
Anna Karlsson
@es
Anna Karlsson
@fr
Anna Karlsson
@nb
Anna Karlsson
@nl
Anna Karlsson
@nn
Anna Karlsson
@sl
type
label
Anna Karlsson
@ast
Anna Karlsson
@da
Anna Karlsson
@de
Anna Karlsson
@en
Anna Karlsson
@es
Anna Karlsson
@fr
Anna Karlsson
@nb
Anna Karlsson
@nl
Anna Karlsson
@nn
Anna Karlsson
@sl
prefLabel
Anna Karlsson
@ast
Anna Karlsson
@da
Anna Karlsson
@de
Anna Karlsson
@en
Anna Karlsson
@es
Anna Karlsson
@fr
Anna Karlsson
@nb
Anna Karlsson
@nl
Anna Karlsson
@nn
Anna Karlsson
@sl
P106
P21
P27
P31
P496
0000-0001-6843-6685